Olanzapine effects on emotional recognition in treatment refractory schizophrenics

被引:0
|
作者
Ibarrarán-Pernas, GY
Cerdán, LF
Guevara, MA
Ramos-Loyo, J
机构
[1] Univ Guadalajara, Inst Neurociencias, Guadalajara 44430, Jalisco, Mexico
[2] Inst Mexicano Seguro Social, Ctr Comunitario Salud Mental 2, Mexico City, DF, Mexico
来源
ACTAS ESPANOLAS DE PSIQUIATRIA | 2003年 / 31卷 / 05期
关键词
refractory schizophrenia; olanzapine; emotional recognition; depression;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction. The main purpose of this study was to determine if olanzapine (OLZ) can improve the ability to recognize emotional expressions, in the facial, prosodic and contextual modalities in treatment refractory schizophrenics (TRS) and, if this could be related to its effects on depressive symptoms. Method. 14 TRS participated in the study. The Calgary Depression Scale and tasks for recognition of facial, prosodic and contextual emotions were applied prior to and 8 weeks after consuming OLZ The results were compared to a control group (CO). Results. TRS obtained lower scores than the CO on the recognition of facial and prosodic emotions. They also showed less empathy to the happiness film and they expressed incongruous answers on the contextual emotions. The TRS increased the number of correct responses for the prosodic recognition of happiness and they showed a reduction in their depressive symptomatology after OLZ treatment. Conclusions. OLZ caused a decrease of the depressive symptoms and improved the interpretation of positive prosodic affective stimuli, an aspect that may facilitate the social adaptation of TRS.
引用
收藏
页码:256 / 262
页数:7
相关论文
共 50 条
  • [1] Brain electrical activity changes in treatment refractory schizophrenics after olanzapine treatment
    Cerdán, LF
    Guevara, MA
    Sanz, A
    Amezcua, C
    Ramos-Loyo, J
    [J]. INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 2005, 56 (03) : 237 - 247
  • [2] Open-label olanzapine trial in schizophrenics refractory to atypical antipsychotics
    Lindenmayer, JP
    Volavka, H
    Iskander, A
    Parak, M
    Kotsaftis, A
    Czobor, P
    Parker, B
    [J]. SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 287 - 287
  • [3] The effects of Clozapine and Haldol on memory functioning in treatment refractory schizophrenics
    Goldman, RS
    Bates, JA
    Bilder, RM
    Kane, J
    Schooler, N
    Marder, S
    [J]. SCHIZOPHRENIA RESEARCH, 1996, 18 (2-3) : XIII3 - XIII3
  • [4] MESORIDAZINE IN TREATMENT-REFRACTORY SCHIZOPHRENICS
    KINON, G
    SAKALIS, G
    TRAFICANTE, LJ
    ARONSON, M
    BOWERS, P
    GERSHON, S
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1979, 25 (04): : 534 - 539
  • [5] COMBINED MESORIDAZINE AND AMANTADINE TREATMENT IN REFRACTORY SCHIZOPHRENICS
    OPLER, LA
    KAY, SR
    VITALHERNE, J
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1985, 37 (02): : 318 - 325
  • [6] Adverse effects of high-dose olanzapine in treatment-refractory schizophrenia
    Bronson, BD
    Lindenmayer, JP
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (03) : 382 - 384
  • [7] Efficacy and adverse effects of olanzapine in the treatment of moderate to severe refractory neuropathic pain
    Yuhong Dai
    Man Zou
    Tingting Huang
    Hong Qiu
    [J]. Oncology and Translational Medicine, 2020, 6 (02) : 47 - 51
  • [8] Impairments in attention and facial emotion recognition in treatment refractory and non refractory schizophrenics evaluated through an odd-ball paradigm
    Ramos, J
    Cerdán, LF
    Guevara, MA
    Amezcua, C
    [J]. REVISTA DE NEUROLOGIA, 2001, 33 (11) : 1027 - 1032
  • [9] Benefit of extending the dosing interval of olanzapine on schizophrenics during maintenance treatment
    Suzuki, Hidenobu
    Hibino, Hiroyuki
    Inoue, Yuichi
    Mikami, Ayako
    Matsumoto, Hideo
    Mikami, Katsunaka
    [J]. ASIAN JOURNAL OF PSYCHIATRY, 2017, 30 : 100 - 101
  • [10] Olanzapine in the treatment of refractory migraine and chronic daily headache
    Silberstein, SD
    Peres, MFP
    Hopkins, MM
    Shechter, AL
    Young, WB
    Rozen, TD
    [J]. HEADACHE, 2002, 42 (06): : 515 - 518